CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
The Global Precision Fermentation Market Size projected to grow at a CAGR of 40.1% from 2026 to 2032, according to a new ...
22hOpinion
Scientists make breakthrough that could give major boost to food supply: 'A huge positive'
On top of improving crop yield and safeguarding the livelihood of many farmers, gene editing research has helped scientists ...
From detox drinks and hair masks to immunity shots and chutneys, amla or Indian gooseberry has quietly stayed at the centre ...
The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption of dietary supplements and functional nutrition products. As ...
RRS Sir David Attenborough scientists are trying to measure the potentially crucial role of ocean manganese, finds. But how ...
Modern Engineering Marvels on MSN
CRISPRi unveils tuberculosis’ fatal respiratory weak point
A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...
9hon MSN
Why your vitamin D might not be working: Foods, supplements, and medications that reduce absorption
Vitamin D absorption is significantly impacted by what you eat and when you take supplements. High-fibre meals, excessive ...
US rare disease drug developer Mirum Pharmaceuticals today announced its entry into a definitive agreement to acquire Bluejay ...
The bacterium that causes TB can hide in liver cells called hepatocytes, and reprogram their metabolism for its own benefit.
Data featured in an ASH oral presentation; LINKER-MM4 is the first clinical trial to evaluate a BCMAxCD3 bispecific monotherapy in NDMM and is part of a broad clinical development program evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback